The biased nature of the inhibitory effect of CD33 on receptors coupled to DAP10 or SAP adaptor proteins described here provides new insights that could help to study the role of CD33 in diseases such as Alzheimer's disease. Here, SH2D1A is linked to early-onset autosomal dominant Alzheimer disease.